Helicobacter pylori cell wall, membrane, and thiol-containing enzymes

This target represents a composite of structural and functional components of the Gram-negative bacterium Helicobacter pylori, including its cell envelope and various essential enzymes. These components are critical for the pathogen's ability to colonize the human stomach, survive the highly acidic environment, and maintain metabolic homeostasis (StatPearls, 2023). Therapeutic agents such as bismuth salts target these sites simultaneously; they disrupt the physical integrity of the cell wall and membrane while inactivating key enzymes like urease and alcohol dehydrogenase through high-affinity binding to sulfhydryl groups (PubMed, 2019). This multi-targeted approach is a cornerstone of bismuth-based quadruple therapy, which is highly effective in eradicating H. pylori and overcoming antibiotic resistance (NCBI, 2021). By inhibiting urease, these drugs prevent the bacteria from creating a protective alkaline microenvironment, thereby rendering them susceptible to gastric acid (Journal of Clinical Gastroenterology, 2017). Consequently, targeting these bacterial structures and enzymes facilitates the healing of gastritis and peptic ulcers while reducing the long-term risk of gastric malignancy.

Other names

H. pylori cellular componentsBismuth targets in Helicobacter pyloriHelicobacter pylori cell envelope and enzymes

Bismuth compounds exert bactericidal effects by binding to the bacterial cell wall and membrane, causing structural disruption, lysis, and detachment of the bacteria from the gastric epithelium. Furthermore, bismuth inhibits multiple essential bacterial enzymes, most notably urease, by binding with high affinity to functional thiol (sulfhydryl) groups, which prevents the bacteria from neutralizing gastric acid and disrupts vital metabolic pathways.